Navigation Links
Lilly CFO Derica Rice Assumes Expanded Responsibilities, Promoted to Executive Vice President

INDIANAPOLIS, Dec. 18 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced that Derica Rice, senior vice president and chief financial officer for Lilly, has assumed expanded responsibilities and has been promoted to executive vice president, global services and chief financial officer, effective January 1.

In this role, Rice will retain his responsibilities as chief financial officer of the company and add responsibility for global services, including the ongoing global services design project, as well as IT and Six Sigma.

"Derica has demonstrated strong leadership and outstanding results during his 19-year career at Lilly," said Lilly Chairman, President and CEO John Lechleiter, Ph.D. "Derica, in his new role, will help ensure that these important functions, aligned with our global services design effort, continue to provide needed support to our business units and our key functions in the most efficient and effective way possible."

Rice joined the company in 1990 as an international treasury associate. He has held numerous leadership roles during his tenure, including chief financial officer for Lilly Canada, executive director and chief financial officer for European operations based in London, and the general manager of Lilly United Kingdom and Republic of Ireland. Prior to becoming Lilly's CFO in 2006, Rice had been the vice president and controller since July 2003.

Born in Decatur, Alabama, Rice received a bachelor's degree in electrical engineering from Kettering University (formerly the GMI Engineering & Management Institute) in 1988 and a master's degree in business administration in 1990 from Indiana University.

In 2009, Rice was selected as one of the "Most Powerful Executives in Corporate America" by Black Enterprise magazine and he was selected as one of Diversity MBA magazine's "Top 100 Under 50 Executives." He serves as a member of the board of directors for Target Corporation, Clarian Health North and The Center for Leadership Development. Rice also serves as a member of the Indiana University Board of Trustees and the Board of Governors of the Indianapolis Museum of Art.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information ? for some of the world's most urgent medical needs. Additional information about Lilly is available at



SOURCE Eli Lilly and Company

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Declares First-Quarter 2010 Dividend
2. FDA Approves Lillys ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
3. Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance
4. FDA Approves Lillys Zyprexa for Two Adolescent Indications
5. Lilly Releases Latest Value of Medicine Resource Guide About Key Issues Facing the Pharmaceutical Industry
6. Lilly Surpasses United Way 2009 Campaign Goal
7. Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
8. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
9. Lilly CEO Lechleiter Calls for Repair of the Engine of Biopharma Innovation
10. Eli Lilly and Company Opens Eco-Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation
11. Lilly Surpasses Energy Efficiency Goals and Celebrates Worldwide Energy Day
Post Your Comments:
(Date:11/30/2015)... 30, 2015 Varian Medical Systems (NYSE: VAR ) ... partnership with Apollo Hospitals Group, the largest hospital chain in ... train radiation technologists in the country. The MoU was signed by ... and Ashok Kakkar , Varian,s India ... India , Varian intends to deploy its Access to ...
(Date:11/30/2015)... and BOSTON , November ... research and develop potential new medicines directed at up ... therapeutic areas. --> PFE ) to research ... 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic ... GPCR structure-guided drug discovery and development company and wholly-owned ...
(Date:11/29/2015)... Nov. 29, 2015  Strengthening its leadership in connected ... PHIA) today announced IntelliSpace Portal 8.0 , the ... visualization platform that helps radiologists detect, diagnose and follow-up ... Radiological Society of North America Annual Meeting (RSNA) ... 8.0 helps address the changing demands in radiology that ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... , ... Two years ago, Debbie Gregory, the CEO of, found herself ... Meditation (TM). After encouraging a number of veterans to go through the program, ... the talk. , TM is becoming one of the best alternative treatments for Post-Traumatic ...
(Date:11/30/2015)... ... November 30, 2015 , ... According to ... Ph.D., a senior scientist at Consumer Reports as supporting a “A Call for ... exposure limits. , The original Nov 2015 CR story titled, “Does Cell-Phone Radiation ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... at the Radiology Society of North America (RSNA) annual meeting, being held November ... growth from 2014. Throughout 2015, the company has completed installations for Integrated ...
(Date:11/30/2015)... ... ... It’s inevitable that everyone will experience death in his or her lifetime. Whether ... among us. It is your perspective, however, that determines how you view death in ... Sky understands that she may see death more frequently than most. As she was ...
(Date:11/30/2015)... Morton Grove, IL (PRWEB) , ... November 30, 2015 , ... ... milestone for an emerging pharmaceutical company. Because it is so important to this key ... titled “Success Factors in your IND Filing” on December 4th at 11am EST. , ...
Breaking Medicine News(10 mins):